Adjuvant Bisphosphonate Therapy in Primary Breast Cancer

This is a clinical practice guideline for women with early stage breast cancer. The guideline examines the use of adjuvant bisphosphonate therapy in these patients. The appropriate choice of bisphosphonates and patient eligibility criteria are discussed. Menopausal status is also specifically addressed.